Association between brachial-ankle pulse wave velocity and the ratio of l-arginine to asymmetric dimethylarginine in patients undergoing coronary angiography

Journal of Cardiology

Volumn 65, Issue 4, 2015, Pages 311-317

  Masaki, Nobuyuki ^a   Hakuno, Daihiko ^a   Toya, Takumi ^a   Shiraishi, Yasunaga ^a   Kujiraoka, Takehiko ^a   Namba, Takayuki ^a   Yada, Hirotaka ^a   Kimura, Kazuo ^a   Miyazaki, Koji ^a   Adachi, Takeshi ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Asymmetric dimethylarginine; Brachial ankle pulse wave velocity; Nitric oxide

Indexed keywords

ARGININE; BRAIN NATRIURETIC PEPTIDE; N(G),N(G) DIMETHYLARGININE; HEMOGLOBIN; N,N'-DIMETHYLARGININE; N,N-DIMETHYLARGININE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; FEMALE; HEART RATE; HEMOGLOBIN BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PULSE WAVE; ANALOGS AND DERIVATIVES; BLOOD; DRUG EFFECTS; HEMATOCRIT; KIDNEY; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; ANKLE BRACHIAL INDEX; ARGININE; BLOOD PRESSURE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HEART RATE; HEMATOCRIT; HEMOGLOBINS; HUMANS; KIDNEY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS;

EID: 84927074097     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2014.06.005     Document Type: Article

References (43)

1. Zieman S.J., Melenovsky V., Kass D.A. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005, 25:932-943.
2. Lee H.Y., Oh B.H. Aging and arterial stiffness. Circ J 2010, 74:2257-2262.
3. Brunner E.J., Shipley M.J., Witte D.R., Singh-Manoux A., Britton A.R., Tabak A.G., McEniery C.M., Wilkinson I.B., Kivimaki M. Arterial stiffness, physical function, and functional limitation: the Whitehall II Study. Hypertension 2011, 57:1003-1009.
4. Yasmin McEniery C.M., Wallace S., Dakham Z., Pusalkar P., Maki-Petaja K., Ashby M.J., Cockcroft J.R., Wilkinson I.B. Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol 2005, 25:372-378.
5. Wilkinson I.B., Franklin S.S., Cockcroft J.R. Nitric oxide and the regulation of large artery stiffness: from physiology to pharmacology. Hypertension 2004, 44:112-116.
6. McEniery C.M., Wallace S., Mackenzie I.S., McDonnell B., Yasmin Newby D.E., Cockcroft J.R., Wilkinson I.B. Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans. Hypertension 2006, 48:602-608.
7. Brandes R.P., Fleming I., Busse R. Endothelial aging. Cardiovasc Res 2005, 66:286-294.
8. Vlachopoulos C., Aznaouridis K., Terentes-Printzios D., Ioakeimidis N., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with brachial-ankle elasticity index: a systematic review and meta-analysis. Hypertension 2012, 60:556-562.
9. Cighetti G., Allevi P., Anastasia L., Bortone L., Paroni R. Use of methyl malondialdehyde as an internal standard for malondialdehyde detection: validation by isotope-dilution gas chromatography-mass spectrometry. Clin Chem 2002, 48:2266-2269.
10. Cesarone M.R., Belcaro G., Carratelli M., Cornelli U., De Sanctis M.T., Incandela L., Barsotti A., Terranova R., Nicolaides A. A simple test to monitor oxidative stress. Int Angiol 1999, 18:127-130.
11. Heresztyn T., Worthley M.I., Horowitz J.D. Determination of l-arginine NG, NG-dimethyl-l-arginine in plasma by liquid chromatography as AccQ-Fluor™ fluorescent derivatives. J Chromatogr B Analyt Biomed Life Sci 2004, B805:325-329.
12. Teerlink T., Nijveldt R.J., de Jong S., van Leeuwen P.A. Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 2002, 303:131-137.
13. Tang W.H., Wang Z., Cho L., Brennan D.M., Hazen S.L. Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk. J Am Coll Cardiol 2009, 53:2061-2067.
14. Imai E., Horio M., Nitta K., Yamagata K., Iseki K., Hara S., Ura N., Kiyohara Y., Hirakata H., Watanabe T., Moriyama T., Ando Y., Inaguma D., Narita I., Iso H., et al. Estimation of glomerular filtration rate by the MDRD study equitation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol 2007, 11:41-50.
15. Koyoshi R., Miura S., Kumagai N., Shiga Y., Mitsutake R., Saku K. Clinical significance of flow-mediated dilation, brachial intima-media thickness and pulse wave velocity in patients with and without coronary artery disease. Circ J 2012, 76:1469-1475.
16. Cho S.W., Kim B.K., Kim J.H., Byun Y.S., Goh C.W., Rhee K.J., Ahn H.S., Lee B.K., Kim B.O. Non-invasively measured aortic wave reflection and pulse pressure amplification are related to the severity of coronary artery disease. J Cardiol 2013, 62:131-137.
17. van der Zwan L.P., Scheffer P.G., Dekker J.M., Stehouwer C.D., Heine R.J., Teerlink T. Systemic inflammation is linked to low arginine and high ADMA plasma levels resulting in an unfavorable NOS substrate-to-inhibitor ratio: the Hoorn Study. Clin Sci 2011, 121:71-78.
18. Kocaman S.A., Sahinarslan A., Biberoglu G., Hasanoglu A., Akyel A., Timurkaynak T., Cengel A. Asymmetric dimethylarginine and coronary collateral vessel development. Coron Artery Dis 2008, 19:469-474.
19. Selcuk M.T., Selcuk H., Temizhan A., Maden O., Ulupinar H., Baysal E., Ozeke O., Sasmaz A. Asymmetric dimethylarginine plasma concentrations and l-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow. Coron Artery Dis 2007, 18:545-551.
20. Usui M., Matsuoka H., Miyazaki H., Ueda S., Okuda S., Imaizumi T. Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure. Life Sci 1998, 62:2425-2430.
21. Anderssohn M., Rosenberg M., Schwedhelm E., Zugck C., Lutz M., Lüneburg N., Frey N., Böger R.H. The l-arginine-asymmetric dimethylarginine ratio is an independent predictor of mortality in dilated cardiomyopathy. J Card Fail 2012, 18:904-911.
22. Seljeflot I., Nilsson B.B., Westheim A.S., Bratseth V., Arnesen H. The l-arginine-asymmetric dimethylarginine ratio is strongly related to the severity of chronic heart failure. No effects of exercise training. J Card Fail 2011, 17:135-142.
23. Visser M., Vermeulen M.A., Richir M.C., Teerlink T., Houdijk A.P., Kostense P.J., Wisselink W., de Mol B.A., van Leeuwen P.A., Oudemans-van Straaten H.M. Imbalance of arginine and asymmetric dimethylarginine is associated with markers of circulatory failure, organ failure and mortality in shock patients. Br J Nutr 2012, 107:1458-1465.
24. Brenner T., Fleming T.H., Rosenhagen C., Krauser U., Mieth M., Bruckner T., Martin E., Nawroth P.P., Weigand M.A., Bierhaus A., Hofer S. l-Arginine and asymmetric dimethylarginine are early predictors for survival in septic patients with acute liver failure. Mediators Inflamm 2012, 2012:210454.
25. Ochiai M., Hayashi T., Morita M., Ina K., Maeda M., Watanabe F., Morishita K. Short-term effects of l-citrulline supplementation on arterial stiffness in middle-aged men. Int J Cardiol 2012, 155:257-261.
26. Angel K., Provan S.A., Mowinckel P., Seljeflot I., Kvien T.K., Atar D. The l-arginine/asymmetric dimethylarginine ratio is improved by anti-tumor necrosis factor-α therapy in inflammatory arthropathies. Associations with aortic stiffness. Atherosclerosis 2012, 225:160-165.
27. Lind L., Larsson A., Teerlink T. l-Arginine is related to endothelium-dependent vasodilation in resistance and conduit arteries in divergent ways - the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Atherosclerosis 2009, 203:544-549.
28. Heffernan K.S., Fahs C.A., Ranadive S.M., Patvardhan E.A. l-Arginine as a nutritional prophylaxis against vascular endothelial dysfunction with aging. J Cardiovasc Pharmacol Ther 2010, 15:17-23.
29. Morris S.M. Arginine metabolism in vascular biology and disease. Vasc Med 2005, 10(Suppl. 1):S83-S87.
30. Dioguardi F.S. To give or not to give? Lessons from the arginine paradox. J Nutrigenet Nutrigenomics 2011, 4:90-98.
31. Haines R.J., Pendleton L.C., Eichler D.C. Argininosuccinate synthase: at the center of arginine metabolism. Int J Biochem Mol Biol 2011, 2:8-23.
32. Erez A., Nagamani S.C., Lee B. Argininosuccinate lyase deficiency-argininosuccinic aciduria and beyond. Am J Med Genet C Semin Med Genet 2011, 157:45-53.
33. Luiking Y.C., Ten Have G.A., Wolfe R.R., Deutz N.E. Arginine de novo and nitric oxide production in disease states. Am J Physiol Endocrinol Metab 2012, 303:E1177-E1189.
34. Morris S.M. Arginases and arginine deficiency syndromes. Curr Opin Clin Nutr Metab Care 2012, 15:64-70.
35. Durante W., Johnson F.K., Johnson R.A. Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol 2007, 34:906-911.
36. Munder M. Arginase: an emerging key player in the mammalian immune system. Br J Pharmacol 2009, 158:638-651.
37. Caplin B., Leiper J. Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators. Arterioscler Thromb Vasc Biol 2012, 32:1343-1353.
38. Kielstein J.T., Donnerstag F., Gasper S., Menne J., Kielstein A., Martens-Lobenhoffer J., Scalera F., Cooke J.P., Fliser D., Bode-Böger S.M. ADMA increases arterial stiffness and decreases cerebral blood flow in humans. Stroke 2006, 37:2024-2029.
39. Weber T., Maas R., Auer J., Lamm G., Lassnig E., Rammer M., O'Rourke M.F., Böger R.H., Eber B. Arterial wave reflections and determinants of endothelial function a hypothesis based on peripheral mode of action. Am J Hypertens 2007, 20:256-262.
40. Böger R.H. The pharmacodynamics of l-arginine. J Nutr 2007, 137(6 Suppl. 2):1650S-1655S.
41. Yokoyama H., Shoji T., Kimoto E., Shinohara K., Tanaka S., Koyama H., Emoto M., Nishizawa Y. Pulse wave velocity in lower-limb arteries among diabetic patients with peripheral arterial disease. J Atheroscler Thromb 2003, 10:253-258.
42. Izuhara M., Shioji K., Kadota S., Baba O., Takeuchi Y., Uegaito T., Mutsuo S., Matsuda M. Relationship of cardio-ankle vascular index (CAVI) to carotid and coronary arteriosclerosis. Circ J 2008, 72:1762-1767.
43. Shirai K., Hiruta N., Song M., Kurosu T., Suzuki J., Tomaru T., Miyashita Y., Saiki A., Takahashi M., Suzuki K., Takata M. Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives. J Atheroscler Thromb 2011, 18:924-938.